Development and validation of the Wisconsin Smoking Withdrawal Scale.

Abstract

The accurate assessment of nicotine withdrawal is important theoretically and clinically. A 28-item scale, the Wisconsin Smoking Withdrawal Scale, was developed that contains 7 reliable subscales tapping the major symptom elements of the nicotine withdrawal syndrome. Coefficients alpha for the subscales range from .75 to .93. This scale is sensitive to smoking withdrawal, is predictive of smoking cessation outcomes, and yields data that conform to a 7-factor structure. The 7 scales predicted intratreatment smoking, chi2(7, N = 163) = 15.19, p = .034. Moreover, the questionnaire is sufficiently brief so that it can be used in both clinical and research contexts.

Cites (25)

1. Diagnostic and Statistical Manual of Mental Disorders
   Williams, Janet B. W., First, Michael · 2013 · Encyclopedia of Social Work
2. Development and validation of brief measures of positive and negative affect: The PANAS scales.
   Watson, David, Clark, Lee Anna, Tellegen, Auke · 1988 · Journal of Personality and Social Psychology
3. Signs and Symptoms of Tobacco Withdrawal
   Hughes, John R. · 1986 · Archives of General Psychiatry
4. Research Advances in Alcohol and Drug Problems
   1984 · Springer eBooks
5. The development and initial validation of a questionnaire on smoking urges
   TIFFANY, STEPHEN T., DROBES, DAVID J. · 1991 · British Journal of Addiction
6. The Health consequences of smoking: nicotine addiction: a report of the Surgeon General
   1989 · Choice Reviews Online
7. Affects separable and inseparable: On the hierarchical arrangement of the negative affects.
   Watson, David, Clark, Lee A. · 1992 · Journal of Personality and Social Psychology
8. Smoking withdrawal symptoms in two weeks of abstinence
   Shiffman, Saul M., Jarvik, Murray E. · 1976 · Psychopharmacology
9. Psychopathology : experimental models
   Jack D. Maser, Martin E. P. Seligman · 1977 · W.H. Freeman eBooks
10. Untitled work
    1986 · PubMed

Show all 25 references

Cited by (20)

1. Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
   Johnson, Matthew W, Garcia-Romeu, Albert, Cosimano, Mary P, Griffiths, Roland R · 2014 · Journal of Psychopharmacology
2. Effects of abstinence from tobacco: Valid symptoms and time course
   Hughes, John · 2007 · Nicotine & Tobacco Research
3. A vaccine against nicotine for smoking cessation: a randomized controlled trial
   Cornuz, Jacques, Zwahlen, Susanne, Jungi, Walter Felix, Osterwalder, Joseph, Klingler, Karl, van Melle, Guy, Bangala, Yolande, Guessous, Idris, Müller, Philipp, Willers, Jörg et al. · 2008 · PLoS ONE
4. Smoking withdrawal dynamics in unaided quitters.
   Piasecki, Thomas M., Niaura, Raymond, Shadel, William G., Abrams, David, Goldstein, Michael, Fiore, Michael C., Baker, Timothy B. · 2000 · Journal of Abnormal Psychology
5. The early time course of smoking withdrawal effects
   Hendricks, Peter S., Ditre, Joseph W., Drobes, David J., Brandon, Thomas H. · 2006 · Psychopharmacology

See all 306